Author

O. Mizrahi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Nachshon· 2 shared H. Tamir· 2 shared M. Schwartz· 2 shared N. Paran· 2 shared N. Stern-Ginossar· 2 shared Y. Finkel· 2 shared Y. Yahalom-Ronen· 2 shared A. Beth-Din· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Nachshon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivNov 25, 2020

SARS-CoV-2 utilizes a multipronged strategy to suppress host protein synthesis

Y. Finkel, A. Gluck, R. Winkler…·N. Stern-Ginossar

This study identifies how SARS-CoV-2 suppresses host protein synthesis through global translation reduction, mRNA degradation, and impaired translation of immune-related transcripts.

DOI 10.1038/s41586-021-03610-3

humanbulk RNA-seq

𝕏 PostBluesky

MicrobiologyNaturePeer-reviewedSep 9, 2020

The coding capacity of SARS-CoV-2

Y. Finkel, O. Mizrahi, A. Nachshon…·N. Stern-Ginossar

This study maps the full coding capacity of SARS-CoV-2 using ribosome profiling, identifying 23 novel translated ORFs and revealing viral translation dominance over host translation.

DOI 10.1038/s41586-020-2739-1

virusproteomics

𝕏 PostBluesky